The differential expression analysis result demonstrated that the FDX1 was highly expressed in tumor tissues than in normal tissues in glioblastoma multiforme (GBM), brain lower-grade glioma (LGG), stomach adenocarcinoma (STAD) (Figure 1A). This evidence concerns the gene FDX1 and glioblastoma.